Oaktree Specialty Lending Corp annual report, FY2023

Oaktree Specialty Lending Corporation (Nasdaq: OCSL) — FY2023 Form 10-K

Reporting period: Fiscal year ended September 30, 2023. Although the request identifies 2023 Q4, this filing is an annual report; the supplied text does not provide a standalone fourth-quarter income statement summary.

Business context

OCSL is an externally managed business development company and regulated investment company (RIC), advised by Oaktree. It lends mainly to middle-market companies with limited access to public or syndicated capital markets. Its objective is current income and capital appreciation. The January 2023 acquisition of Oaktree Strategic Income II (OSI2) expanded the portfolio and share count.

Key financial metrics

MetricFY2023 / September 30, 2023FY2022 / September 30, 2022
Total investment income$379.3 million$262.5 million
Net investment income (NII)$180.7 million; $2.51 per share$148.6 million; $2.45 per share
Net increase in net assets from operations$117.3 million; $1.63 per share$29.2 million; $0.48 per share
Net realized gains (losses)$(33.2) million$17.2 million
Net unrealized appreciation (depreciation)$(28.6) million$(136.2) million
Net assets / NAV per share$1.516 billion / $19.63$1.246 billion / $20.38
Cash flow from operations$228.8 million$22.4 million
Cash and restricted cash$145.5 million$26.4 million
Debt outstanding$1.660 billion$1.350 billion
Asset coverage ratio187.7%188.6%
  • Investment portfolio fair value was $2.892 billion, compared with $2.494 billion a year earlier. The portfolio included 143 companies; 94.0% was debt investments and 86.5% was senior secured loans.
  • Debt investments’ weighted average annual yield was approximately 12.7%, including 11.2% in cash payments. This is a portfolio yield before company expenses, not a stockholder return.
  • 86.2% of debt investments at fair value bore floating rates. Weighted average borrowing cost was 7.0%, including the effect of an interest rate swap.
  • Net debt-to-equity was 1.01x. Undrawn capacity under company credit facilities was $907.5 million, subject to borrowing-base and other limits. The reported net cash increase for the year was $119.2 million.
  • Net NII margin proxy—NII as a percentage of average net assets—was 12.57%, versus 11.36%. Net expenses as a percentage of average net assets increased to 13.81% from 8.45%.

Material changes versus FY2022

  • Investment income rose 44.5%, primarily due to higher reference rates on floating-rate loans and the larger portfolio following the OSI2 merger.
  • Net expenses increased 79.5% to $198.5 million, chiefly reflecting $64.7 million of higher interest expense, increased income incentive fees, and a larger asset base. FY2022 expenses included an $8.8 million reversal of previously accrued capital-gains incentive fees.
  • NII increased $32.1 million, but realized performance weakened: net realized losses were $33.2 million versus gains of $17.2 million. Unrealized depreciation narrowed to $28.6 million from $136.2 million.
  • The OSI2 merger issued 15.86 million shares and contributed assets; the filing records a one-time $20.7 million unrealized loss from merger-related accounting adjustments. Shares outstanding rose to 77.23 million from 61.13 million.
  • NAV per share declined 3.7% to $19.63 from $20.38. FY2023 distributions were $2.61 per share, compared with $1.95 in FY2022.

Outlook, risks and unusual items

  • Management gave no numerical earnings, originations, or distribution guidance. It described uncertainty from inflation, higher interest rates, potential recession, and geopolitical conflicts, while stating it sees opportunities in selective situational, sponsor, stressed-sector, rescue, and public-credit lending.
  • Four investments were on non-accrual at year-end, representing 2.4% of debt investments at cost and 1.8% at fair value; there were none a year earlier. A significant share of portfolio valuations relies on estimates: $2.620 billion was classified as Level 3. The auditor identified Level 3 investment valuation as a critical audit matter, while issuing an unqualified opinion on the financial statements.
  • Key risks include borrower stress from higher rates and inflation, defaults and lower recoveries, illiquid and judgment-based valuations, leverage and secured-creditor priority, and conflicts from the external adviser’s management of other funds. Accrued PIK and original issue discount income can precede cash receipt.
  • Unfunded commitments totaled $232.7 million, including $205.6 million for portfolio companies and $27.1 million for joint ventures; approximately $154.2 million of portfolio-company commitments could be drawn immediately.
  • Debt included $710 million under credit facilities and $950 million principal of unsecured notes, including $300 million of 7.10% notes issued in August 2023. The 2025 and 2027 notes are effectively subordinated to secured debt; substantially all relevant assets are pledged under credit facilities. The company reported compliance with its syndicated-facility financial covenants.
  • The company reported no pending material legal proceedings. Management and the auditor concluded internal control over financial reporting was effective.
  • After year-end, the Board declared a $0.55-per-share quarterly distribution and a $0.07-per-share special distribution, payable December 29, 2023.

Most important facts for investors to verify

  • Whether non-accrual exposures, realized losses, and portfolio-company financial stress are increasing after September 30, 2023.
  • The assumptions and independent support for Level 3 valuations, especially given the $2.620 billion Level 3 balance and the auditor’s critical audit matter.
  • Whether higher asset yields continue to exceed rising borrowing costs, expenses, and incentive fees, and how rate changes affect borrower repayment capacity.
  • Available borrowing capacity and covenant headroom after considering collateral eligibility, unfunded commitments, distributions, and the 150% statutory asset-coverage threshold.
  • Whether NII and taxable income support the distribution level; FY2023 estimated taxable income was $165.8 million, and the filing says the estimate was not final.
  • The effects of OSI2 merger accounting and share issuance on reported results, NAV per share, and future income comparisons.